On Dec. 24, 2019, the National Institute of Allergy and Infectious Diseases (NIAID) established the Infectious Diseases Clinical Research Consortium. The consortium will encompass NIAIDﾒs Vaccine and Treatment Evaluation Units. NIAID will fund $29 million per year for seven years for the program.